Mitochondria-targeted nanosystem-mediated delivery of cryptotanshinone for enhanced suppression of non-small cell lung cancer - 09/01/26
, Hanzhou Wang b
, Yuanchen Zhao b
, Chao Xue a
, Rui Liu a
, Baojin Hua a, ⁎ 
Abstract |
Lung cancer remains the most prevalent and deadliest malignant tumor worldwide, and there is an urgent need to develop novel antitumor therapies to achieve satisfactory treatment outcomes. Traditional Chinese Medicine (TCM) is a traditional therapeutic approach in China, and extensive clinical and basic research has shown its excellent antitumor efficacy. Dysregulation of lipid metabolism is one of the significant characteristics of malignant tumors, with mitochondria playing a crucial role. Inducers of the cyclic guanosine monophosphate-adenosine monophosphate synthase/stimulator of interferon genes (cGAS/STING) pathway can influence the lipid metabolism of tumor cells. Here, we designed a polydopamine-based nanomaterial targeting mitochondria and encapsulated Cryptotanshinone to enhance cGAS/STING-mediated lipid metabolism and mitochondrial apoptosis, thereby exerting a targeted inhibitory effect on primary tumor lesions and ex vivo tumor cells. Consequently, our engineered nanosystem represents a novel strategy for promoting tumor lipid metabolism reprogramming and mitochondrial apoptosis through the modulation of the cGAS/STING pathway, thus addressing the significant challenge associated with regulating mitochondrial function to suppress Non-Small Cell Lung Cancer (NSCLC).
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | The potent anti-tumor effects of cryptotanshinone-polydopamine small molecular drug nanoparticles (PPRC). |
• | PPRC induced a dose-dependent reduction in mitochondrial membrane potential in A549 cells, with concurrent disruption of mitochondrial function. |
• | PPRC enhanced cryptotanshinone's ability to affect mitochondrial apoptosis and metabolism-related lipid levels. |
• | A polydopamine-based nanomaterial targeting mitochondria and encapsulated cryptotanshinone to enhance cGAS/STING pathway. |
Keywords : Cryptotanshinone, Non-small cell lung cancer, Lipid metabolism, Mitochondrial apoptosis, CGAS/STING pathway
Plan
Vol 194
Article 118927- janvier 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
